she assured her. i feel sure. that the world sat with the biggest composer of all time i constantly begin to imagine. a world class horn player single willis on a visit to journey of discovery. 2 world without a total start september 16th on the w. . it's a 20 year old company that's never brought a product to market driven biotech firm cura fact is now an investor darling as it races to develop cope at 19 vaccine we'll talk to the c.e.o. . also and show why or part gets the boot from germany's blue chip index it's a place that might surprise you. show i'm stephen beardsley in berlin it's good to

have you with us the coronavirus pandemic is reshaping the biotech industry investors are piling into small often unproven companies in hopes that they can produce a vaccine in the coming months those companies in turn are spending big to expand production facilities for vaccines that aren't yet fully tested or certified it's a gamble for both investor and company and it reflects the urgency for a vaccine as well as the potential to make money. german pharmaceutical company cura voc 20 years old 480 employees and it dreams of change in the wild has its sights set on the most sought after of prizes a coronavirus vaccine and the newly listed company is making progress when went public in new york on friday it shares rose 249 percent during the 1st day of trading those who go to an alley may have struck it rich. cura back is just one of

many corporate vaccine hopefuls $170.00 companies from all over the world including the us china japan the u.k. and india are also in the race. last week russia claimed a breakthrough president vladimir putin proudly declared they were the 1st to approve a vaccine which he said his own daughter had been vaccinated but scientists the russian vaccine named sputnik 5 is really ready. what's beyond doubt is that thanks to high tech methods used by the likes of cure research is moving faster than ever in normal times it would take 10 to 15 years to get a vaccine to market some companies have reached the clinical trial phase in a matter of months regulators are expecting a breakthrough as early as next year no other product in the world has a larger potential market many nations have already placed orders for hundreds of

millions of doses cure back plans to produce a 1000000000 per year if it's faxing comes to fruition the question is whose will hit the market 1st. and for all this i'm joined now by franz verna hasi c.e.o. of care vax it's good to have you on the show. when will it pay for when do you expect your company to have a vaccine ready for the public and how much will it cost produce we are planning to have the vaccine or somewhere mid next year depending certainly on the data you're running clinical trial with will be prudent after 1st clinical data it would we expect in september october. and you know how much of the writing. the right thing at the end of the day it will be somewhere based on the cost of goods and certainly or what went into the technology which has been invested into for the last 20 years in order to make it happen but it should be affordable so you

shouldn't overdo it with the price there are certain settings already done we are on a very low base cost of goods and that should be reflected in the price there as well so i would guess somewhere between 10 and 15 years 1015 years are you already in discussions with governments to supply certain amounts of the vaccine yes of course we have got something to offer and if you are seeing that governments are doing this advanced purchase agreements i'm certain we are in discussions. can you give us any names of the governments that your instructions with right now but at the moment are current sorry. your company is 20 years old has yet to bring a product to market why do you believe it can deliver now in such a short timeframe. well the technology has been developed during all of this years in order to get it to can all of you in that in this stage that you can really

develop products on it it takes a certain period of time and this m r n a technology what we have is 'd very versatile so if you know the virus the secrets of the rise because we're not working with the virus directly but with the sequence of the sequence of the virus and this is what we are coding on the are in a which has been in humans and this is really a rep at development certainly the reparative element is due to the fact with the regulatory authorities as well that we are facing a pandemic which needs certain requirements but always taken an eye on safety and security enter ability for the patient. so. if i understand correctly the technology has improved the regulatory environment has improved but should we believe that m r n and therapies vaccines in this case are going to suddenly they're going to work in the next few months just because the urgency is greater or is there a chance that something might fail during a larger phase 3 test for example. of course the risk of development is always

there what the are in a can do is that you really fastly can code exactly the protein the want of protein for the very target on the are an aid to produce it also record. because a synthetic process full of yarn a manufacturing but it doesn't take the risk of product development of course and this is why you are running clinical trials and there will be loads of data not only with us but also our own 8 players when you are running clinical trials and then you will see what the data would bring and one should not forget we are dealing with a virus where nobody knows exactly all the elements of the virus what you need in order to be protected how long you're protected it's a new virus but the are in a can really address through to the fact that you can develop rather quickly on the basis of r.n.a. to really have a vaccine and then to test it and we should mention 2 of those other firms they're also working as area beyond tac all danna do you consider this

a race with other biotech firms. well 1st of all it is a race against the time there is a pandemic outbreak there with a huge effect on society nobody doubts about this one and therefore it's a race and. not that much against the competitors and at the moment and hopefully all of those fixings would work there is a raise also to have enough capacity you always start in the beginning and you can't cover everyone and therefore it's good that other players are. in the game as well what kind of pressure does that put on your company to be raising capacity that is production level at the same time you're building a vaccine that you don't even know if it's going to work or or achieve public approval. how essential is that the you get this right well it is enormously essential for 4 different reasons 1st of all the company is running for 20 years and that's exactly why the company has been funded to make a difference to give a cure in a situation like this one to be fast versatile and of course safe and terrible and

hopefully a few cases there as well so it's a huge pressure it's a huge pressure because there is a pandemic situation out there and certainly everybody is looking to us for good reason because we have got something to offer and this is what we have to prove so the pressure is there but it is a positive pressure because also our employees have been working on it for all these years expected for this moment to make a difference and i hope that. the german government was an early investor in you at the beginning of the pandemic i should say 300000000 euros just back then to climb out now that you've raised successfully so much more money well i certainly cannot talk for the german government but the investment and there was a press conference also with the minister of economy saying ok this is a long term investment and i'm in for several weeks now i think there's not a long term investment there is so much more we can do because it's not only about cove it is really changing the medicine today and put it on our in

a in different regard to the quality of protein therapies as well. all right that was front burner house c.e.o. of cure of act thank you so much for joining us thank you very much having me and now to some of the other global business stories making news u.s. president donald trump has called for a boycott of tire maker good year after employees in kansas were told not to wear clothing with politically affiliated slogans such as make america great again or magda in a tweet trump wrote quote don't buy goodyear tires they announce the ban on mag hats. air b.n. b. has filed for an initial public offering just months after the coronavirus up into the global travel industry in may the company was valued at $18000000000.00 during a funding round short term rental firm cut almost a quarter of its workforce in response to a sharp fall as a man's. online food ordering company delivery hero set to replace wire cards on

germany's dax index bilin based firm and some of the world's biggest takeaway delivery brands fin tech firm wire card leave the dax on friday following the scandal over a 2000000000 euro hole in its balance sheets. and for more on that let's go to financial correspondent correspondent leigh bards in frankfurt early delivery hero replacing wire car that seems strange to me how did it get there. yeah it is a little bit odd a company that's not doing any business in germany yes it was founded here it's headquartered here but it sold off its german operations last year it's never made a profit when you take the fact that when it sold its german operations it had a net profit for that year but its operations are losing money but it did fulfilled accretive area that count from the view of the torture but also of the stock market operator and that's market value that's high it's about 20000000000 euros. still the stock has shot up this year by about 40 percent lots more people ordering in

because of the corona pandemic this year and trade volume is also so good that the top other candidates are right so it meets the criteria this is really underline one of the weaknesses of the dax in that it doesn't have real tech companies under its umbrella. yeah i mean the wire card scandal highlighted the kind of criteria that the doctor bills i had to for doc's membership and the question has gotten going and people live lamented for quite some time that the docs was too industry or in or into too old industry too old german business and more techs belonging to the critics demand of the doctor bills or it should be expanded to give a better broader picture and you shouldn't let companies that have never had a profit become members that could go very wrong that's also what people fear or a lot of questions about the facts these days after that why are hard scandal.

there for us in frankfurt thank you. and wrapping up take a look at this a pair of spectacles thought to have belonged to mahatma gandhi are going on auction in the city of bristol on friday the iconic rounds rims were found stuffed in the auction houses letterbox employees connected them to a local 80 year old man who says his uncle met the future indian indian and independence leader rather while working in south africa for oil producer b.p. the online bids for the frames have already surpassed 55000 euros. just sitting there in the mailbox that's your business update you can always find out more at ease of use dot com slash business as always thanks for watching.

combating the corona pandemic. where does research stand. what are scientists learning. background information and. our corona update. covert 19 special next on d w

d 2 you know that 77 percent. are younger than 65. that's me and me and you. and you know what it's time all voices. on the 77 percent to talk about the issues that. this is where you cut. the 77 percent this weekend on d w. as this generation continues its fight against the coronavirus concerns are growing about the next generation. some like this medical worker a staying on the front lines despite being pregnant. others are putting off their dreams of parenthood until

a treatment can be found. some had predicted a baby boom joining lock down but initial research suggests u.s. birth rates have fallen. that leaves many wondering what long term effects covert 19 could have on fertility rates. great time to get pregnant. some of my friends have been through stressful times others have coasted through this crisis making the most of taking it easy joint pregnancy and many more delaying their plans to make a family google searches for terms like morning sickness and pregnancy tests have fallen scientists say the data collected points were 15 percent drop in birth rates in the united states in the coming months the picture varies around the world but all in all it looks like fewer babies are higher impact on the wellbeing of new moms and affects on older generations further down the track. a month before this moment. have lost her husband to the coronavirus. pressed

self infected but asymptomatic she gave birth to.